{"name":"Pierre Fabre Dermo Cosmetique","slug":"pierre-fabre-dermo-cosmetique","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Infectious Disease","slug":"infectious-disease","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Amorolfine (Antifungal)","genericName":"Amorolfine (Antifungal)","slug":"amorolfine-antifungal","indication":"Onychomycosis (fungal nail infection)","status":"marketed"}]},{"name":"Dermatology","slug":"dermatology","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"immunology","drugs":[{"name":"RV3391A","genericName":"RV3391A","slug":"rv3391a","indication":"Dermatological indication (specific indication not publicly disclosed)","status":"phase_3"}]}],"pipeline":[{"name":"Amorolfine (Antifungal)","genericName":"Amorolfine (Antifungal)","slug":"amorolfine-antifungal","phase":"marketed","mechanism":"Amorolfine inhibits fungal sterol synthesis by blocking lanosterol demethylase, disrupting the integrity of the fungal cell membrane.","indications":["Onychomycosis (fungal nail infection)","Dermatophyte and non-dermatophyte fungal infections of the skin"],"catalyst":""},{"name":"RV3391A","genericName":"RV3391A","slug":"rv3391a","phase":"phase_3","mechanism":"RV3391A is a topical agent developed for dermatological use, likely targeting inflammatory or proliferative skin conditions.","indications":["Dermatological indication (specific indication not publicly disclosed)"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMifkFVX3lxTE1kTXRTX1NDQTZUMXZjUDdfZDN6Ujg3TVphbm5Od05TU3dNSktvQ2MyOVk5QVhCSnpSMU5xNURrbEhGZmd4anlUZ21PYmZxaHZSRXdfZXFSQTZ4aHdZaGhVeW9fSTMzOGVPUXVsN25vYVRjeG1WVVIzN2l1b1NXZw?oc=5","date":"2026-04-01","type":"pipeline","source":"China Daily","summary":"Pierre Fabre to boost investment in China - China Daily","headline":"Pierre Fabre to boost investment in China","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqAJBVV95cUxPYlFMblZ5czVlbFhicXAwdEN0a3lXM0NrcU5NLWlGRVFPWE9pakNJbk5JbDd3S2xMaE9DSGc4bDJjY1luaEYxUWF6dFZUaGdTcGRrZzFXVGRQbkhJYUtrX21KZWwtbHRhdUM1WlIyWWdzZU5VTWEtZzdPZVNscUJiX0xIZTkwMHZMcDY3YUVOeEVoQTFLMmFYUHpGeVV4eVl5QzdrRW1pOXQySE5sUGdubUVFeHRYSnRZOENmOWFMOWQyNUpMdDljT1dONFB0LVhHaURKTFBDUWFld0F1RnhXWW9mVkNFZkxmdzNQRDhpODItbkg5b25aVkVVcThYcGpZWjFQbnlmZ1lFZVg5TkhtdmRFR1RfYlVVaEh3YkZkbFV2UjZpTHVtag?oc=5","date":"2026-03-11","type":"pipeline","source":"prnewswire.com","summary":"Pierre Fabre Laboratories is exploring the potential of Artificial Intelligence to launch a new generation of clinical studies in dermo-cosmetics - prnewswire.com","headline":"Pierre Fabre Laboratories is exploring the potential of Artificial Intelligence to launch a new generation of clinical s","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMieEFVX3lxTE1KWXhXSlpJNjNESVYwNFhmMVlrMTRVc3hHbWMxV1YtQUFXWVhjUUN3ajdoMkNfSlAtMlUyOXphRFZHRzdmelNoYy02ZnpaR0wwSUNINkRmcTBCekRMNHRmUGIxSldJd1V4S052cEZPUXVCRUNIRVZ3eQ?oc=5","date":"2025-11-30","type":"pipeline","source":"AfricaBrief","summary":"Pierre Fabre Launches Avène, Ducray Skincare Brands in Kenya - AfricaBrief","headline":"Pierre Fabre Launches Avène, Ducray Skincare Brands in Kenya","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMifEFVX3lxTFA1d2Q5U2NTczh6OV9WOTVCY3YtTlBfMDlkWEdkNHdiWTl1eFAyTHYtS0FZaWh4d3NjY2lhSEg2dHZOak1oYjFzRlZIRlFCSEpVRDNvRFZ1eFI3OWprOG9JWHdEUWx3UXMtRmJGRVFhdHRza0c2Q2tqTkhVMDg?oc=5","date":"2025-06-30","type":"pipeline","source":"NJBIZ","summary":"Pierre Fabre USA makes in-state HQ move to Secaucus - NJBIZ","headline":"Pierre Fabre USA makes in-state HQ move to Secaucus","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilwFBVV95cUxOLWZaS0lWa2Zqc3JQLXlRbF94RzQ0eVdUaDgtY1k5S3B1NkVjN0xNYnRUeG56UHhFWTJDbzFwckp1S21DN3FpTllpdExiYmUyQmFDcDFreUtWUFEwY01JeENWTUlSQ05WWDBqdmpFR28tOS1pQkJOMDdUYzhYajg2dFZNRDVKUk5jbHh4OHkzVWcxR0JtTGI0?oc=5","date":"2025-06-23","type":"pipeline","source":"New Jersey Business Magazine","summary":"France’s Pierre Fabre Opens New US Location in Secaucus - New Jersey Business Magazine","headline":"France’s Pierre Fabre Opens New US Location in Secaucus","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiogFBVV95cUxNRi10QWcyV1FMMS1vZURVdEdOdmVJUFFNZVZManRQaTlJY1JuN3VTanRKb0F0UEhwYjdZcnVHUVRxRGIxUDAxM3JWZjdvdWFzaXk5RTVpVXM4YjgySFNZdjFCMUMxWkN4WjI4UHVJWW5QYlNlSFJydG91RGwxQWs1LTJvSFF0aURUQlQyNmJsSjM0UV9oenEzVXdzZHNXVHNGUGc?oc=5","date":"2025-06-19","type":"pipeline","source":"ROI-NJ","summary":"Pierre Fabre Laboratories opens new office in Secaucus - ROI-NJ","headline":"Pierre Fabre Laboratories opens new office in Secaucus - ROI","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiugFBVV95cUxPZm52ellUbjNHdzhYOS1hSFM1MHdqZVhUTlV0b3ppd2cxeFhnUWNudk0wQmViZmhLbTExWFBiejdOYnJMWlYwcHQxeG9VaGZST2w4NHVad1dXNk9tSXJ2TC04bElneGZzdzBoZGx5Y3RoTV9EQ25iWWxkV0FkUHQtdVdCcDNkejg4MWVuZXVJa25fZ2RONXdoV2QwMVEtVTNPcHptU19nUzZFTW5KZmk2Y2prWTdweDdFbUE?oc=5","date":"2025-05-30","type":"trial","source":"pharmaphorum","summary":"Innovation, real-world data, and precision medicine: Pierre Fabre and the lung cancer space - pharmaphorum","headline":"Innovation, real-world data, and precision medicine: Pierre Fabre and the lung cancer space","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiggFBVV95cUxPSVMwQWVwTlN2UjYzRjlNd2ZqTXpDYzdrRndWYVpfVkRmWWktSklqQmsxdDMwazVYMlp3Y2tpc3FPaWw3TkE5T1l0RmRrNzB1XzFXWEU1QnJHVmlxWXJyV0ZxTlRDTlczd2lvM2h3YkVSemx1dUt4ZE9LXzZHczBNb0pB?oc=5","date":"2023-09-22","type":"pipeline","source":"Cosmetics Business","summary":"Pierre Fabre Laboratories invests in skin care and supplements brand MiYé - Cosmetics Business","headline":"Pierre Fabre Laboratories invests in skin care and supplements brand MiYé","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijgFBVV95cUxNcy0wMkpDWEt5LUwwYmRkZGFQcUJScWxTNWFNYXYwQWtWQzduWWVfX0huN0UyVzZ0WnU5SkpCMTBZYmtLUDN3N1loYXp6VnlEazZlVVJGZ1lsRTd0d1RLZ3BCWmsyNWhwb21TR2k3TGUyXzVGSUFzbjRSZmFTcXducVZ3MDlvLUh2ZUxRWWFR?oc=5","date":"2023-09-12","type":"deal","source":"Contract Pharma","summary":"Pierre Fabre Labs Acquires Vertical Bio - Contract Pharma","headline":"Pierre Fabre Labs Acquires Vertical Bio","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijgFBVV95cUxNNXZjY1VHQTR1Sl9TMEpyOXVmdGpXREFLQjFhQVdOcXcwV0ZKV01NWXJPT29Yby1NWXJsVS1sYm1TMjZudG1LU255MDVpOXZOVGNQN0NGTlZJeXZ0emxZSVVvc18zVHBEbUprY0YyMklWb1pUOEZGRkx0eDdwNGJweWNONXBRNHg3bVVtSURR?oc=5","date":"2023-05-09","type":"deal","source":"BeautyMatter","summary":"Pierre Fabre Has Acquired Dermocosmetics Brand Même - BeautyMatter","headline":"Pierre Fabre Has Acquired Dermocosmetics Brand Même","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTE4yVzlCVDE4T2U3NkZqaDliNDdxWU15QWpaY3JDcHh6R050NDFTTEdvT2E1Rm5IOTFQaGJrZTl3SVNOYWlfVEtjNnh6X3dVUHVCdU9qY3BVWWpvTHBUbHFtd2RyOFRFN2VNT0dqWkZR0gFyQVVfeXFMTUhWWG4tdnc0UUVTeEpJa3U2WnVueGZSQnRISkk1S3pzYU5YeEVIVGYxQ2dqbmw1b0pyRlFXSXRrWGVTQ3o2TEtKNUwwR2ZFUkJjc1lyX1BoZVliRHhYdWk0UGIxTHhlcUMtbVQyR0pzSkln?oc=5","date":"2023-01-05","type":"pipeline","source":"koreabiomed.com","summary":"Sanofi Consumer Healthcare Korea appoints former Pierre-Fabre Dermo Cosmetique Korea GM as new CEO - koreabiomed.com","headline":"Sanofi Consumer Healthcare Korea appoints former Pierre-Fabre Dermo Cosmetique Korea GM as new CEO","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi4AFBVV95cUxPU1QtOWNIcnVGMU5JZUNIZlZkNC0wTnJUTC1XQU11MEo5aWdYSnp4OEttTDdzOUZMX182alE5TWNWQVkxZXdXWXN2ZjdsbWdoLXQ1ODBYZlY2cHpFb2hYd3Y2VzF4RVRjLUwtQTJYeVU4V2RveHRJcWFsSmg5WGZuNVBmOXRRdTF5dXVSZ0hXYk5xZ2hYQWRPdmoyVU16eUtnSXpxV0xrYXhOb0FhaHc0UU9OSFVvME1ZRkhvX2lFbk1IUTNHd3k1bHdhcTNONUFTd1NBYmhYWXViR0VodWRSTQ?oc=5","date":"2022-11-01","type":"pipeline","source":"Healthcare Packaging","summary":"Bormioli Pharma, Pierre Fabre Develop New PET Packaging - Healthcare Packaging","headline":"Bormioli Pharma, Pierre Fabre Develop New PET Packaging","sentiment":"neutral"}],"patents":[],"drugCount":2,"phaseCounts":{"marketed":1,"phase_3":1},"enrichmentLevel":0,"visitCount":4,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}